India and Russia have unveiled two major collaboration initiatives, the setting up of an Indian pharmaceutical manufacturing facility in Russia and a new joint effort to produce fertilisers, marking a major expansion of their economic engagement.
The announcements were part of the 23rd India–Russia Annual Summit, where both countries outlined plans to strengthen cooperation in key sectors. The proposed pharma unit in Russia will draw on India’s global reputation in affordable, high-quality drug manufacturing. The facility is expected to produce a range of essential medicines, with scope for vaccines, oncology products and other critical therapies.
Agriculture and chemicals formed another key pillar of the talks. India and Russia agreed to deepen collaboration by jointly producing fertilisers, including plans for a dedicated urea manufacturing plant in Russia. This project aims to ensure a stable long-term supply of fertilisers for India and reduce exposure to global pricing volatility.
These initiatives fit within the broader India–Russia Economic Roadmap 2030, a long-term framework that charts future cooperation in pharmaceuticals, fertilisers, shipping, minerals, manufacturing and technology.
Addressing the India–Russia Business Forum, Prime Minister Narendra Modi urged global and Russian companies to align with India’s “Make in India, Partner with India” vision. He highlighted India’s strengths in pharmaceuticals, textiles, technology and vaccine development, and encouraged deeper industry partnerships across supply chains, including APIs and radiopharmaceuticals.
The new agreements underline the growing strategic trust between New Delhi and Moscow, signalling a shared commitment to stability and economic resilience amid shifting global dynamics.